SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-019242
Filing Date
2023-11-20
Accepted
2023-11-20 16:01:53
Documents
81
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nhwk-20230930x10q.htm   iXBRL 10-Q 2009616
2 EX-31.1 nhwk-20230930xex31d1.htm EX-31.1 26403
3 EX-31.2 nhwk-20230930xex31d2.htm EX-31.2 25786
4 EX-32.1 nhwk-20230930xex32d1.htm EX-32.1 8770
5 EX-32.2 nhwk-20230930xex32d2.htm EX-32.2 9436
  Complete submission text file 0001558370-23-019242.txt   10270020

Data Files

Seq Description Document Type Size
6 EX-101.SCH nhwk-20230930.xsd EX-101.SCH 73567
7 EX-101.CAL nhwk-20230930_cal.xml EX-101.CAL 102402
8 EX-101.DEF nhwk-20230930_def.xml EX-101.DEF 276003
9 EX-101.LAB nhwk-20230930_lab.xml EX-101.LAB 692215
10 EX-101.PRE nhwk-20230930_pre.xml EX-101.PRE 509119
75 EXTRACTED XBRL INSTANCE DOCUMENT nhwk-20230930x10q_htm.xml XML 1980960
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
NightHawk Biosciences, Inc. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35994 | Film No.: 231422726
SIC: 2834 Pharmaceutical Preparations